Burning Rock Biotech (BNR) EBT (2019 - 2025)

Burning Rock Biotech's EBT history runs 7 years deep, the most recent figure standing at -$2.1 million for Q4 2025.

• In Q4 2025, EBT rose 80.07% year-over-year to -$2.1 million; the TTM figure through Dec 2025 stood at -$7.6 million (up 83.98% YoY), while the FY2025 annual figure was -$7.7 million, up 83.52% from the prior year.
• EBT was -$2.1 million for Q4 2025 at Burning Rock Biotech, up from -$2.3 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$1.3 million in Q2 2025 to a low of -$41.2 million in Q1 2022.
• Historically, EBT has averaged -$20.7 million across 5 years, with a median of -$23.3 million in 2023.
• The sharpest annual moves came in 2021 and 2025: EBT slumped 247.3% in 2021, then jumped 91.11% in 2025.
• A 5-year view of EBT shows it stood at -$39.6 million in 2021, then grew by 21.51% to -$31.1 million in 2022, then increased by 26.96% to -$22.7 million in 2023, then jumped by 54.14% to -$10.4 million in 2024, then surged by 80.07% to -$2.1 million in 2025.
• The last three EBT figures came in at -$2.1 million (Q4 2025), -$2.3 million (Q3 2025), and -$1.3 million (Q2 2025), per Business Quant data.